RxDoctor Payments Data

Trish Millard, MD

Medical Oncology · Charlottesville, VANPI 1770873986

Payments from drug & device makers

What this record shows

That places this record below the midpoint for medical oncology clinicians in VA, where the typical reported total is $926.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$255,089in research payments, 2019–2025

Across 9 payments — averaging $28,343 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$255K

How this compares

$0 in reported general payments places this provider in the 0th percentile of 95 medical oncology providers in Virginia.

See all medical oncology providers in Virginia

Medicare billing

Part B allowed, 2024
$44,224
Medicare patients
171
Services billed
386

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
KisqaliRibociclib Succinate20$285,395
IbrancePalbociclib17$269,407
EliquisApixaban16$12,190
Letrozole118$3,371
Anastrozole30$322
Tamoxifen Citrate12$255
Duloxetine Hcl11$187
Furosemide12$10

Paid to pharmacies, not to this prescriber.

Other medical oncology in Charlottesville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →